These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9862270)

  • 1. Effects of lipids and lipoproteins on thrombosis and rheology.
    Rosenson RS; Lowe GD
    Atherosclerosis; 1998 Oct; 140(2):271-80. PubMed ID: 9862270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoproteins and the haemostatic system in atherothrombotic disorders.
    Miller GJ
    Baillieres Clin Haematol; 1994 Sep; 7(3):713-32. PubMed ID: 7841607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation.
    Holy EW; Besler C; Reiner MF; Camici GG; Manz J; Beer JH; Lüscher TF; Landmesser U; Tanner FC
    Thromb Haemost; 2014 Nov; 112(5):1024-35. PubMed ID: 25056722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.
    Vehkavaara S; Silveira A; Hakala-Ala-Pietilä T; Virkamäki A; Hovatta O; Hamsten A; Taskinen MR; Yki-Järvinen H
    Thromb Haemost; 2001 Apr; 85(4):619-25. PubMed ID: 11341495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus.
    Ludwig S; Dharmalingam S; Erickson-Nesmith S; Ren S; Zhu F; Ma GM; Zhao R; Fenton JW; Ofosu FA; Velthuis HT; van Mierlo G; Shen GX
    Diabetes Res Clin Pract; 2005 Nov; 70(2):110-8. PubMed ID: 16188573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-thrombosis interface.
    Mitropoulos KA
    Br Med Bull; 1994 Oct; 50(4):813-32. PubMed ID: 7804733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of VLDL and remnant particles on platelets.
    Olufadi R; Byrne CD
    Pathophysiol Haemost Thromb; 2006; 35(3-4):281-91. PubMed ID: 16877877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells.
    Markle RA; Han J; Summers BD; Yokoyama T; Hajjar KA; Hajjar DP; Gotto AM; Nicholson AC
    J Cell Biochem; 2003 Sep; 90(1):23-32. PubMed ID: 12938153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.
    Meigs JB; Mittleman MA; Nathan DM; Tofler GH; Singer DE; Murphy-Sheehy PM; Lipinska I; D'Agostino RB; Wilson PW
    JAMA; 2000 Jan; 283(2):221-8. PubMed ID: 10634338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum triglycerides and blood coagulation factors VII and X, and plasminogen activator inhibitor-1.
    Ohni M; Mishima K; Nakajima K; Yamamoto M; Hata Y
    J Atheroscler Thromb; 1995; 2 Suppl 1():S41-6. PubMed ID: 9225231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the fibrinolytic system and hemorheology with symptoms in patients with carotid occlusive disease.
    Soinne L; Saimanen E; Malmberg-Céder K; Kovanen P; Lindsberg PJ; Kaste M; Lassila R
    Cerebrovasc Dis; 2005; 20(3):172-9. PubMed ID: 16088112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein.
    Siess W
    Pathophysiol Haemost Thromb; 2006; 35(3-4):292-304. PubMed ID: 16877878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lipids on thrombotic mechanisms in atherosclerosis.
    Tousoulis D; Davies G; Ambrose J; Tentolouris C; Stefanadis C; Toutouzas P
    Int J Cardiol; 2002 Dec; 86(2-3):239-47. PubMed ID: 12419562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current views of activating and regulatory mechanisms of blood coagulation].
    Osaki T; Ichinose A
    Nihon Rinsho; 2014 Jul; 72(7):1206-11. PubMed ID: 25163309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustering of cardiovascular risk factors: targeting high-risk individuals.
    Genest J; Cohn JS
    Am J Cardiol; 1995 Jul; 76(2):8A-20A. PubMed ID: 7604805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus as a prothrombotic condition.
    Grant PJ
    J Intern Med; 2007 Aug; 262(2):157-72. PubMed ID: 17645584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.